Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Journal of Medicinal Chemistry
|
November 30, 2022
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties
Ping Sun, Jing Wang, Khadija S Khan, et al.
Autophagy
|
February 22, 2015
SIRT5 regulation of ammonia-induced autophagy and mitophagy
Lucia Polletta, Enza Vernucci, Ilaria Carnevale, et al.
Nature Communications
|
February 13, 2015
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Tobias Rumpf, Matthias Schiedel, Berin Karaman, et al.
Journal of Medicinal Chemistry
|
May 29, 2026
Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint Blockade
Nithya Gajendran, Manasa Suresh, Sebastian J Marquez R, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
Hany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.
Nature Communications
|
December 20, 2017
A 1-phytase type III effector interferes with plant hormone signaling
Doreen Blüher, Debabrata Laha, Sabine Thieme, et al.
Cell Reports
|
April 3, 2013
The SH2 domain interaction landscape
Michele Tinti, Lars Kiemer, Stefano Costa, et al.
Bioorganic Chemistry
|
April 19, 2025
Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation
Noreen Hemida, Dalia S El-Gamil, Ahmed K ElHady, et al.
RSC Medicinal Chemistry
|
April 21, 2025
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer
Aya Fathy, Amro Allam, Ahmed K ElHady, et al.
Molecular Biology and Evolution
|
June 17, 2026
Functional Divergence and Structural Changes of class IV Histone Deacetylases (HDACs) Across the Tree of Life
Zora Nováková, Pavla Bartošová-Sojková, Julia Kudláčová, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Journal of Medicinal Chemistry
|
November 30, 2022
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties
Ping Sun, Jing Wang, Khadija S Khan, et al.
Autophagy
|
February 22, 2015
SIRT5 regulation of ammonia-induced autophagy and mitophagy
Lucia Polletta, Enza Vernucci, Ilaria Carnevale, et al.
Nature Communications
|
February 13, 2015
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
Tobias Rumpf, Matthias Schiedel, Berin Karaman, et al.
Journal of Medicinal Chemistry
|
May 29, 2026
Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint Blockade
Nithya Gajendran, Manasa Suresh, Sebastian J Marquez R, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity
Hany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.
Nature Communications
|
December 20, 2017
A 1-phytase type III effector interferes with plant hormone signaling
Doreen Blüher, Debabrata Laha, Sabine Thieme, et al.
Cell Reports
|
April 3, 2013
The SH2 domain interaction landscape
Michele Tinti, Lars Kiemer, Stefano Costa, et al.
Bioorganic Chemistry
|
April 19, 2025
Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation
Noreen Hemida, Dalia S El-Gamil, Ahmed K ElHady, et al.
RSC Medicinal Chemistry
|
April 21, 2025
Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer
Aya Fathy, Amro Allam, Ahmed K ElHady, et al.
Molecular Biology and Evolution
|
June 17, 2026
Functional Divergence and Structural Changes of class IV Histone Deacetylases (HDACs) Across the Tree of Life
Zora Nováková, Pavla Bartošová-Sojková, Julia Kudláčová, et al.
Page
of 11